These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 38319453)

  • 21. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
    Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
    Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CLU (clusterin) promotes mitophagic degradation of MSX2 through an AKT-DNM1L/Drp1 axis to maintain SOX2-mediated stemness in oral cancer stem cells.
    Praharaj PP; Patra S; Mishra SR; Mukhopadhyay S; Klionsky DJ; Patil S; Bhutia SK
    Autophagy; 2023 Aug; 19(8):2196-2216. PubMed ID: 36779631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plastic persisters: revival stem cells in colorectal cancer.
    Tape CJ
    Trends Cancer; 2024 Mar; 10(3):185-195. PubMed ID: 38071119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.
    Takahashi H; Ishii H; Nishida N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M
    Ann Surg Oncol; 2011 Apr; 18(4):1166-74. PubMed ID: 21125339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lentivirus-mediated RNA interference of clusterin enhances the chemosensitivity of EJ bladder cancer cells to epirubicin in vitro.
    Lu J; Luo JH; Pang J; Cao JZ; Wu RH; Tong ZT; Chen W; Xie D
    Mol Med Rep; 2012 Nov; 6(5):1133-9. PubMed ID: 22895628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs.
    Zhao Y; Li Y; Sheng J; Wu F; Li K; Huang R; Wang X; Jiao T; Guan X; Lu Y; Chen X; Luo Z; Zhou Y; Hu H; Liu W; Du B; Miao S; Cai J; Wang L; Zhao H; Ying J; Bi X; Song W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):379. PubMed ID: 31455383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visualization and targeting of LGR5
    Shimokawa M; Ohta Y; Nishikori S; Matano M; Takano A; Fujii M; Date S; Sugimoto S; Kanai T; Sato T
    Nature; 2017 May; 545(7653):187-192. PubMed ID: 28355176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J.
    Lourda M; Trougakos IP; Gonos ES
    Int J Cancer; 2007 Feb; 120(3):611-22. PubMed ID: 17096323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glyceryl trinitrate‑induced cytotoxicity of docetaxel‑resistant prostatic cancer cells is associated with differential regulation of clusterin.
    Bouaouiche S; Magadoux L; Dondaine L; Reveneau S; Isambert N; Bettaieb A; Jeannin JF; Laurens V; Plenchette S
    Int J Oncol; 2019 Apr; 54(4):1446-1456. PubMed ID: 30720069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of cancer stem cell drug resistance in the human colorectal cancer cell lines HCT116 and SW480.
    Butler SJ; Richardson L; Farias N; Morrison J; Coomber BL
    Biochem Biophys Res Commun; 2017 Aug; 490(1):29-35. PubMed ID: 28576498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer.
    Hsu HC; Liu YS; Tseng KC; Hsu CL; Liang Y; Yang TS; Chen JS; Tang RP; Chen SJ; Chen HC
    Int J Colorectal Dis; 2013 Nov; 28(11):1535-46. PubMed ID: 23784051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells.
    Planutis AK; Holcombe RF; Planoutene MV; Planoutis KS
    Anticancer Drugs; 2015 Oct; 26(9):942-7. PubMed ID: 26196680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RBCK1 contributes to chemoresistance and stemness in colorectal cancer (CRC).
    Liu ML; Zang F; Zhang SJ
    Biomed Pharmacother; 2019 Oct; 118():109250. PubMed ID: 31545242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clusterin paradigm in prostate and breast carcinogenesis.
    Rizzi F; Bettuzzi S
    Endocr Relat Cancer; 2010 Mar; 17(1):R1-17. PubMed ID: 19903745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients.
    Yang S; Tang W; Azizian A; Gaedcke J; Ströbel P; Wang L; Cawley H; Ohara Y; Valenzuela P; Zhang L; Lal T; Sinha S; Rupin E; Hanna N; Ghadimi BM; Hussain SP
    Carcinogenesis; 2022 Dec; 43(12):1198-1210. PubMed ID: 36426859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells.
    Legge DN; Shephard AP; Collard TJ; Greenhough A; Chambers AC; Clarkson RW; Paraskeva C; Williams AC
    Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30792270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.
    Mangiapane LR; Nicotra A; Turdo A; Gaggianesi M; Bianca P; Di Franco S; Sardina DS; Veschi V; Signore M; Beyes S; Fagnocchi L; Fiori ME; Bongiorno MR; Lo Iacono M; Pillitteri I; Ganduscio G; Gulotta G; Medema JP; Zippo A; Todaro M; De Maria R; Stassi G
    Gut; 2022 Jan; 71(1):119-128. PubMed ID: 33436496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.